PRGO Q1 2018 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena

PRGOPerrigo Company plc

$1B

Q1 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.2B+1.9% YoY

Gross Profit

$493M40.5% margin

Operating Income

$156M12.8% margin

Net Income

$81M6.6% margin

EPS (Diluted)

$0.57

QoQ Revenue Growth

-5.2%

Cash Flow

Operating Cash Flow

$172M

Free Cash Flow

$159M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$11.6B

Total Liabilities

$5.4B

Stockholders' Equity

$6.2B

Cash & Equivalents

$687M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.2B	$1.2B	+1.9%
Gross Profit	$493M	$464M	+6.1%
Operating Income	$156M	$129M	+21.6%
Net Income	$81M	$72M	+12.8%

Revenue Segments

Consumer Self-Care Americas

$602M49%

Consumer Self-Care International

$401M33%

RX Pharmaceuticals

$214M18%

Geographic Segments

UNITED STATES

$786M64%

Europe

$362M30%

Other Geographical Areas

$69M6%

IRELAND

$5M0%